Fucomannogalactan and glucan from mushroom Amanita muscaria: structure and inflammatory pain inhibition

Carbohydr Polym. 2013 Oct 15;98(1):761-9. doi: 10.1016/j.carbpol.2013.06.061. Epub 2013 Jul 1.

Abstract

A fucomannogalactan (FMG-Am) and a (1→3), (1→6)-linked β-D-glucan (βGLC-Am) were isolated from Amanita muscaria fruiting bodies. These compounds' structures were determined using mono- and bi-dimensional NMR spectroscopy, methylation analysis, and controlled Smith degradation. FMG-Am was shown to be a heterogalactan formed by a (1→6)-linked α-D-galactopyranosyl main chain partially substituted at O-2 mainly by α-L-fucopyranose and a minor proportion of β-D-mannopyranose non-reducing end units. βGLC-Am was identified as a (1→3)-linked β-D-glucan partially substituted at O-6 by mono- and a few oligosaccharide side chains, which was confirmed after controlled Smith degradation. Both the homo- and heteropolysaccharide were evaluated for their anti-inflammatory and antinociceptive potential, and they produced potent inhibition of inflammatory pain, specifically, 91±8% (30 mg kg(-1)) and 88±7% (10 mg kg(-1)), respectively.

Keywords: (1→3), (1→6) β-d-Glucan; Amanita muscaria; Anti-inflammatory; Fucomannogalactan; Pain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amanita / chemistry*
  • Animals
  • Female
  • Formaldehyde / adverse effects
  • Fruiting Bodies, Fungal / chemistry
  • Galactans / chemistry*
  • Galactans / isolation & purification
  • Galactans / pharmacology*
  • Galactans / therapeutic use
  • Glucans / chemistry*
  • Glucans / isolation & purification
  • Glucans / pharmacology*
  • Glucans / therapeutic use
  • Inflammation / complications
  • Male
  • Mice
  • Molecular Weight
  • Nociception / drug effects
  • Pain / chemically induced
  • Pain / complications*
  • Pain / drug therapy*
  • Solubility
  • Structure-Activity Relationship

Substances

  • Galactans
  • Glucans
  • Formaldehyde